Skip to main content

SZ 363 (Repaglinide 2 mg)

Pill with imprint SZ 363 is Yellow, Capsule-shape and has been identified as Repaglinide 2 mg. It is supplied by Sandoz Inc.

Repaglinide is used in the treatment of diabetes, type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 2 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for SZ 363

Repaglinide 2 mg SZ 363

Repaglinide

Imprint
SZ 363
Strength
2 mg
Color
Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Meglitinides
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sandoz Inc.
National Drug Code (NDC)
00781-5150 (Discontinued)
Inactive Ingredients
corn starch, calcium phosphate dibasic anhydrous, glycerin, magnesium stearate, meglumine, microcrystalline cellulose, poloxamer 188, polacrilin potassium, magnesium silicate, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.